Seizures during interferon alpha therapy: Three cases in dermatology;Crises épileptiques généralisées: Un effet secondaire de l'interféron alpha: 3 Cas

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 2 I, 2003, Pages 202-204

  Legroux Crespel, E ^a,b   Lafaye, S ^a   Mahe E ^a   Picard Dahan, C ^a   Crickx, B ^a   Sassolas, B ^b   Descamps, V ^a  

^a BICHAT HOSPITAL   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; MALE; MELANOMA; MYCOSIS FUNGOIDES; RELAPSE; SEIZURE;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; MELANOMA; MIDDLE AGED; MYCOSIS FUNGOIDES; SEIZURES; SKIN NEOPLASMS;

EID: 0345269147     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-6.
2. Ameen M, Russell-Jones R. Seizures associated with interferon-alpha treatment of cutaneous malignancies. Br J Dermatol 1999;41:386-7.
3. Dierckx RA, Michotte A, Schmedding E, Ebinger G, Degeeter T, Van Camp B. Unilateral seizures in a patient with hairy cell leukemia treated with interferon. Clin Neurol Neurosurg 1985;87:209-12.
4. Hibi H, Itoh K, Kamiya T, Yamada Y, Shimoji T. Grand mal like attack by interferon injection in case of renal cell carcinoma. Hinyokika Kiyo 1991;37:69-72.
5. Shakil AO, Di Bisceglie AM, Hoofnagle JH. Seizures during alpha interferon therapy. J Hepatol 1996;24:48-51.
6. Woynarowski M, Socha J. Seizures in children during interferon alpha therapy. J Hepatol 1997;26:956-7.
7. Valentini P, Mariotti P, Ngalikpima CJ, Angelone DF, Ranno O. Seizures in an interferon-treated child. Dig Liver Dis 2001;33:363-5.
8. Janssen HL, Berk L, Vermeulen M, Schalm SW. Seizures associated with low-dose alpha-interferon. Lancet 1990;336:1580.
9. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer RJ. Adverse drug reaction monitoring: doing it the French way. Lancet 1985;2:1056-8.
10. Seno H, Inagaki T, Itoga M, Miyaoka T, Ishino H. A case of seizures 1 week after the cessation of interferon-alpha therapy. Psychiatry Clin Neurosci 1999;53:417-20.
11. Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991;41:672-6.
12. Nozaki O, Takagi C, Takaoka K, Takata T, Yoshida M. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C. Clin Neurosci 1997;51:175-80.
13. De Sarro GB, Masuda Y, Ascioti, Audino MG, Nistico G. Behavioral and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxane. Neuropharmacology 1990;29:167-79.
14. Bender CM, Monty EJ, Kerr ME. Potential mechanisms of interferon neurotoxicity. Cancer Pract 1996;4:35-9.
15. Vial T, Choquet-Kastylevsky G, Liautard C, Descotes J. Endocrine and neurological adverse effects of the therapeutic interferons. Toxicology 2000;142,161-72.
16. Laffaioli RV, Fiorenza L, D'Avino M, Frasci G, La Mura G, Grossi D. Neurotoxic effects of long-term treatment with low-dose alpha 2B interferon. Curr Ther Res 1990;48:403-8.
17. Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J et al. Interferon-associated retinopathy. Arch Ophtalmol 1993;111:350-6.